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A 69-year-old man was admitted with complaints of chest pain. Three years earlier, he had radical surgery because 
of esophageal adenocarcinoma staged pT3N1M0. In the 
following 3 years up to admission, he developed a metasta-
sis to his scar, followed by metastases to his liver, and local 
recurrence causing dysphagia. An esophageal stent was ini-
tially placed, but with recurring dysphagia, another stent and 
radiotherapy (30 Gy, 10 fractions) was needed to relieve his 
dysphagia. Later, he received palliative chemotherapy with 
etoposid, 5-fluorouracil (5-FU), and leukovorin with palliative 
intent. After 5-FU infusion, he had acute chest pain and dys-
pnea. 5-FU-induced toxicity was initially suspected because 
the electrocardiograph revealed atrial fibrillation. However, 
a plain chest radiograph revealed a pneumopericardium. A 
computed tomography scan of the thorax showed pericardial 
fluid and air. A fistula between the esophagus and pericardium 
was suspected, but the patient was considered too fragile for 
surgical intervention. Eight days later, he was feeling well in 
the morning, but at noon he suddenly died without sign of 
distress. A postmortem examination suggested cause of death 
to be a tamponade of the heart because of rapid filling of blood 
in the pericardium after the atrial perforation.
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FIGURE 1.  An overview taken from the cardial perspective 
with a white probe going through the 3-mm large atrial–
esophageal perforation and the pericardio–esophageal fistula 
of 2 cm.
FIGURE 2.  The atrial–espohageal perforation viewed from 
the atrium.
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